Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

ANGO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: April 20, 2026

Report Source: 2026 3rd Quarter Report

Analyst's Ratings for AngioDynamics Inc (ANGO)

Based on 10 analysts giving stock ratings to AngioDynamics Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
30
Buy
60
Hold
10
Sell
0
Strong Sell
0
AngioDynamics Inc

AngioDynamics Inc. Stock Analysis ANGO

United States Health Care Small Cap Report:
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 675 full-time employees. The company went IPO on 2004-05-27. The firm is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. The company designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.
Read More

AngioDynamics Inc (ANGO) Chart

Key Statistics of AngioDynamics Inc (ANGO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$12.35$12.66

Today's Open

$12.39

Volume

286.19K

P/E Ratio (TTM)

-

52 Week Range

$8.36$13.99

Market Cap

494.17M

Avg. Volume

344.78K

Dividend Yield

-

Financial Metrics & Statements of AngioDynamics Inc (ANGO)

FAQ's for AngioDynamics Inc (ANGO)

  • According to Musaffa’s Shariah screening methodology, AngioDynamics Inc (ANGO) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes AngioDynamics Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in AngioDynamics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of AngioDynamics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of AngioDynamics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of AngioDynamics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.